These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 19413038)

  • 21. Malfeasance on an industrial scale.
    Prescrire Int; 2013 Feb; 22(135):32. PubMed ID: 23444493
    [No Abstract]   [Full Text] [Related]  

  • 22. Compensation for and prevention of occupational disease.
    American Public Health Association
    Am J Public Health; 1984 Mar; 74(3):292-5. PubMed ID: 11644114
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Experimentation on humans in biomedical research: implications for the industry of recent legislation and cases.
    Standridge LW
    Women Lawyers J; 1977; 63(3):88-95. PubMed ID: 11663032
    [No Abstract]   [Full Text] [Related]  

  • 24. Malpractice reform: one state's example.
    Saxton JW; Finkelstein MM
    Manag Care Interface; 2003 Jul; 16(7):45-8. PubMed ID: 12908218
    [TBL] [Abstract][Full Text] [Related]  

  • 25. DTP vaccine related injury: an examination of proposed vaccine injury compensation legislation.
    Murray PC
    J Contemp Health Law Policy; 1987; 3():233-51. PubMed ID: 11645601
    [No Abstract]   [Full Text] [Related]  

  • 26. Presumption of innocence: FDA's authority to regulate the specifics of prescription drug labeling and the preemption debate.
    Dorfman HL; Quinn VM; Brophy EA
    Food Drug Law J; 2006; 61(4):585-622. PubMed ID: 17180765
    [No Abstract]   [Full Text] [Related]  

  • 27. The role of the federal government in protecting citizens from communicable diseases.
    Morgenstern MS
    Univ Cincinnati Law Rev; 1978; 47(4):537-71. PubMed ID: 11664964
    [No Abstract]   [Full Text] [Related]  

  • 28. Assessing the impact of federal and state preemption in public health: a framework for decision makers.
    Pertschuk M; Pomeranz JL; Aoki JR; Larkin MA; Paloma M
    J Public Health Manag Pract; 2013; 19(3):213-9. PubMed ID: 22759986
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Safety, supply, and suits--litigation and the vaccine industry.
    Kesselheim A
    N Engl J Med; 2011 Apr; 364(16):1485-7. PubMed ID: 21506740
    [No Abstract]   [Full Text] [Related]  

  • 30. The Sunshine Act: it's for real now.
    Katayama AC
    WMJ; 2013 Apr; 112(2):96-7. PubMed ID: 23758019
    [No Abstract]   [Full Text] [Related]  

  • 31. The case for preemption of prescription drug failure-to-warn claims.
    Kim CH
    Food Drug Law J; 2007; 62(2):399-422. PubMed ID: 17632969
    [No Abstract]   [Full Text] [Related]  

  • 32. An idea whose time has come: Compensation for vaccine-related injuries and death in India.
    Nadimpally S; Banerjee S; Venkatachalam D; Bhagianadh D
    Indian J Med Ethics; 2017; 2(2):93-98. PubMed ID: 28512074
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Medical malpractice and tort reform. Issue brief.
    Berry MD
    Issue Brief Health Policy Track Serv; 2012 Dec; ():1-19. PubMed ID: 23297458
    [No Abstract]   [Full Text] [Related]  

  • 34. Compensating Pharmaceutical Injuries in the Absence of Fault.
    Rowin MA
    Food Drug Law J; 2014; 69(3):447-70, ii. PubMed ID: 27382858
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immunity for immunizations: tort liability, biodefense, and Bioshield II.
    Mayer L
    Stanford Law Rev; 2007 Apr; 59(6):1753-90. PubMed ID: 17593591
    [No Abstract]   [Full Text] [Related]  

  • 36. Legal and regulatory perspectives in mass immunization programs.
    Ladimer I
    Insur Law J; 1976 Aug; (643):. PubMed ID: 11664613
    [No Abstract]   [Full Text] [Related]  

  • 37. When vaccine injury claims go to court.
    Stewart AM
    N Engl J Med; 2009 Jun; 360(24):2498-500. PubMed ID: 19516030
    [No Abstract]   [Full Text] [Related]  

  • 38. Immunization injuries: proposed compensatory mechanisms--an analysis.
    Ohta LC
    Conn Law Rev; 1978; 11(1):147-79. PubMed ID: 11665022
    [No Abstract]   [Full Text] [Related]  

  • 39. States weigh in. Legislatures helped stop push for national cap.
    Romano M
    Mod Healthc; 2003 Aug; 33(32):10-1. PubMed ID: 12931529
    [No Abstract]   [Full Text] [Related]  

  • 40. Vaccine bills aim to reduce maker's risks.
    Gapen P
    Am Med News; 1985 Apr; 28(16):2, 31. PubMed ID: 11649596
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.